Once feared HIV drug gets WHO nod as first choice
|
Dolutegravir
(DTG), a drug previously feared to cause deformities in unborn children, is
now the preferred HIV treatment option, even among women of ...
|
View article...
View article...
FDA slaps clinical hold on multiple Gilead HIV trials
Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid safety concerns. View article...